Peer Review History

Original SubmissionMarch 23, 2020
Decision Letter - Elena Ambrosino, Editor

PONE-D-20-08318

Experiences of a web-based psycho-educational intervention targeting sexual dysfunction and fertility distress in young adults with cancer - a self-determination theory perspective.

PLOS ONE

Dear Mrs Micaux Obol,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Jun 26 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Elena Ambrosino

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

Reviewer #3: N/A

Reviewer #4: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: No

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Additional comments are as follows:

Q1 How did you measure the level of psychological situation like; loneliness and normalizing problems your patients? And when should be the specialist stop the program?

Q2 There are physiological different between women and men for sexual health after treatment, I think it is very important add some sentences about effect of treatment on sexual health in men and woman. And How treatment (Radiation, chemotherapy Therapy) Can Affect the Sex Life?

Q4 Line 103 P5: authors state that "Practical obstacles to using the program were mainly related to technical difficulties ..." do you have suggestions for solution these problems?

Q3 Line 173 P8: authors state that "On the other hand, some participants did not feel their competence …" how many patients?

Note: As commented above, overall the study is nice and has big potential.

Reviewer #2: The subject is suitable for the growing use of internet for medical and healthcare, especially considering the current crisis internationally.

Any additional research info finding support for cancer are much needed.

Reviewer #3: Overall is an interesting study, but I have the following concerns and comments:

- Introduction is clear and well defined as well as the objectives.

- The methods section could be improved with the adoption of a research protocol. In this case the COREQ is indicated, despite the fact that the manuscript contains almost every aspect covered by the protocol. Even though, such adoption is recommended for compliance purposes.

- The data presented in the “Context” section could be improved with further data about the participants, especially with the specific information instead of “some reported”, or “About half”, or “A few”. Such precision is relevant since the discussion also relies on these aspects. In other words, the authors mention characteristics they want and expect about the subjects, but they do not exactly present the characteristics of those who participated.

- Discussion is broad and goes to the point.

- References are relevant and up to date.

Reviewer #4: Overall, the study presents good points about cancer survivors’ sexual and reproductive health.

Although the self-determination theory perspective and deductive approach, according to three predetermined themes, can lead to the loss of some important data and concerns of target population.

However, despite the authors substantial explanations in study limitations, there is still a big question about gender proportion in the main RCT.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Mohamed Hadi Mohamed Abdelhamid

Reviewer #2: Yes: Dr Lily Abedipour MD

Reviewer #3: No

Reviewer #4: Yes: Seyed Ali Azin

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Review Comments to the Author

We wish to thank the reviewers for very valuable comments. Please see or answers in italics directly after each comment.

Reviewer #1: Additional comments are as follows:

Q1 How did you measure the level of psychological situation like; loneliness and normalizing problems your patients? And when should be the specialist stop the program?

Answer Q1. The present study is part of a larger RCT with measurements at baseline, post-intervention (directly after end of program) and short-term follow up (12 weeks after end of program). Participants (n=265) were assessed with PROMs for physical and mental health as part of the quantitative evaluation of the intervention. These results will be published separately. Concerning the subsample of 28 men and women in the present qualitative study, the individual levels on these outcome measures were not taken into consideration and therefore we have not sought or reported the exact scores of the 28 participants. In a few of the interviews, negative feelings such as anxiety, grief, loneliness were expressed. In these cases, the interviewer(s) took care to separate the research interview from a more informal conversation at the end of the interview, intending to provide some support and referral to counselling or other healthcare professionals if needed.

Q2 There are physiological different between women and men for sexual health after treatment, I think it is very important add some sentences about effect of treatment on sexual health in men and woman. And How treatment (Radiation, chemotherapy Therapy) Can Affect the Sex Life?

Answer Q2. We thank the reviewer for this valuable comment and have extended the Background section with information on the medical and physiological consequences of cancer and its treatment on the sexual health of both men and women,

Q4 Line 103 P5: authors state that "Practical obstacles to using the program were mainly related to technical difficulties ..." do you have suggestions for solution these problems?

Answer Q4. We have complemented the context description with a figure illustrating stated reasons for non-use of the program, including technical problems. We have also extended the discussion section with a paragraph on the implications of technical difficulties.

Q3. Line 173 P8: authors state that "On the other hand, some participants did not feel their competence …" how many patients?

Answer Q3. Since the present study has a qualitative design, we want to be cautious about making quantitative claims when describing the results. Instead we strive for describing the whole spectrum of participants’ experiences. In order to clarify this passage, we have rephrased some sentences but without adding quantitative descriptors.

Note: As commented above, overall the study is nice and has big potential.

Reviewer #3: Overall is an interesting study, but I have the following concerns and comments:

- Introduction is clear and well defined as well as the objectives.

- The methods section could be improved with the adoption of a research protocol. In this case the COREQ is indicated, despite the fact that the manuscript contains almost every aspect covered by the protocol. Even though, such adoption is recommended for compliance purposes.

We thank the reviewer for this suggestion and have added the COREQ checklist to the supplementary file. The manuscript and supplementary files have been revised with addition of the few points from the COREQ that were not covered in the previous version.

- The data presented in the “Context” section could be improved with further data about the participants, especially with the specific information instead of “some reported”, or “About half”, or “A few”. Such precision is relevant since the discussion also relies on these aspects. In other words, the authors mention characteristics they want and expect about the subjects, but they do not exactly present the characteristics of those who participated.

Answer: We agree that the Context section was too brief and have incorporated a table detailing as much participant data as possible without compromising the confidentiality and privacy of participants.

Reviewer #4: Overall, the study presents good points about cancer survivors’ sexual and reproductive health.

Although the self-determination theory perspective and deductive approach, according to three predetermined themes, can lead to the loss of some important data and concerns of target population.

However, despite the authors substantial explanations in study limitations, there is still a big question about gender proportion in the main RCT.

Answer: We thank the reviewer for this very relevant comment. The question of gender proportion is also our concern and we have added a few more sentences in the Discussion section about this issue Certainly, it will also be discussed in our future publications reporting the results and process of the RCT.

Attachments
Attachment
Submitted filename: Response to reviewers.docx
Decision Letter - Elena Ambrosino, Editor

Experiences of a web-based psycho-educational intervention targeting sexual dysfunction and fertility distress in young adults with cancer - a self-determination theory perspective.

PONE-D-20-08318R1

Dear Dr. Micaux Obol,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Elena Ambrosino

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #3: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: No comment, the authors have adequately addressed my comments raised in a previous round of review and I feel that this manuscript is now acceptable for publication.

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Mohamed Hadi Mohamed Abdelhamid

Reviewer #3: Yes: Bianca Bianco

Formally Accepted
Acceptance Letter - Elena Ambrosino, Editor

PONE-D-20-08318R1

Experiences of a web-based psycho-educational intervention targeting sexual dysfunction and fertility distress in young adults with cancer - a self-determination theory perspective

Dear Dr. Micaux Obol:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Elena Ambrosino

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .